6 research outputs found
Evaluation of a modified double-disc synergy test for detection of extended spectrum β-lactamases in AMPC β-lactamase-producing proteus mirabilis
The detection of extended-spectrum β-lactamases (ESBLs) in
gram-negative bacteria that produce AmpC β-lactamases is
problematic. In the present study, the performance of modified
double-disc synergy test (MDDST) that employs a combination of cefepime
and piperacillin-tazobactam for the detection of proteus mirabilis
producing extended spectrum and AmpC β-lactamases was evaluated
and compared with double-disc synergy test (DDST) and NCCLS phenotypic
disc confirmatory test (NCCLS-PDCT). A total of 90 clinical isolates of
P. mirabilis , which met the CLSI (Clinical and Laboratory Standards
Institute) screening criteria that these had broth microdilution (BMD)
MIC of ≥2 mg/mL for at least one extended spectrum cephalosporin
[ceftazidime (CAZ), cefotaxime (CTX) and cefpodoxime], were selected
for the study. MDDST detected ESBLs in 40/90 of the isolates, whereas
DDST detected ESBLs in only 25 isolates. NCCLS-PDCT could detect ESBLs
in 39 isolates using CAZ and CAZ + clavulanic acid (CLA) combination,
whereas CTX and CTX + CLA combination could detect only 37 isolates as
ESBL positive. As many as 34/40 ESBL positive isolates were confirmed
to be AmpC β-lactamase positive by the modified three-dimensional
test (MTDT). MDDST and NCCLS-PDCT could detect ESBLs in all the 34 AmpC
positive isolates, whereas DDST could detect ESBLs in only 19 isolates.
The study demonstrated that MDDST is superior to DDST and as sensitive
as NCCLS-PDCT. However, MDDST seems to have enhanced potential for the
detection of ESBLs in AmpC β-lactamase-producing P. mirabilis
Identification of AmpC Beta-Lactamases Using Phenotypic Tests and PCR in Clinical Isolates of Klebsiella spp. and Escherichia coli
Veillonella as a cause of chronic anaerobic pneumonitis
SummaryAnaerobes are not well recognized as a cause of chronic respiratory infections. A 44-year-old man was referred for evaluation of a progressive pulmonary disease of 7-month duration characterized by hemoptysis and fever. For these complaints, based on the radiological picture, he had already received antituberculous therapy without any relief. He was also subjected to bronchial artery embolization prior to referral. Evaluation of the patient led to a diagnosis of chronic anaerobic pneumonitis. Anaerobic culture of the computed tomography-guided transthoracic aspirate grew Fusobacterium and Veillonella species. Within 2 weeks of therapy with oral clindamycin, there was a dramatic relief in hemoptysis. This was accompanied by remarkable radiological clearance. This report underscores the importance of Veillonella species as a potential respiratory pathogen. A high index of suspicion is required to diagnose chronic anaerobic pneumonitis, which can mimic pulmonary tuberculosis, especially in tuberculosis endemic regions
Genotyping of methicillin-resistant Staphylococcus aureus in the Sultan Qaboos University Hospital, Oman reveals the dominance of Panton–Valentine leucocidin-negative ST6-IV/t304 clone
The objective of this study was to determine the prevalence and distribution of methicillin-resistant Staphylococcus aureus (MRSA) genotypes circulating at a tertiary hospital in the Sultanate of Oman. A total of 79 MRSA isolates were obtained from different clinical samples and investigated using antibiogram, pulsed-field gel electrophoresis (PFGE), staphylococcal chromosome cassette mec (SCCmec), Spa typing and multilocus sequence typing (MLST). The isolates were susceptible to linezolid, vancomycin, teicoplanin, tigecycline and mupirocin but were resistant to tetracycline (30.4%), erythromycin (26.6%), clindamycin (24.1%), trimethoprim (19.0%), ciprofloxacin (17.7%), fusidic acid (15.2%) and gentamicin (12.7%). Molecular typing revealed 19 PFGE patterns, 26 Spa types and 21 sequence types. SCCmec-IV (86.0%) was the dominant SCCmec type, followed by SCCmec-V (10.1%). SCCmec-III (2.5%) and SCCmec-II (1.3%) were less common. ST6-IV/t304 (n = 30) and ST1295-IV/t690 (n = 12) were the dominant genotypes followed by ST772-V/t657 (n = 5), ST30-IV/t019/t021 (n = 5), ST22-IV/t852 (n = 4), ST80-IV/t044 (n = 3) and 18 single genotypes that were isolated sporadically. On the basis of SCCmec typing and MLST, 91.2% of the isolates were classified as community-associated MRSA and 8.8% of the isolates (consisting of four ST22-IV/t852, one ST239-III/t632, one ST5-III/t311 and one ST5-II/t003) were classified as healthcare-associated MRSA. The study has revealed the dominance of a Panton–Valentine leucocidin-negative ST6-IV/t304 clone and provided insights into the distribution of antibiotic resistance in MRSA at the tertiary hospital in Oman. It also highlights the importance of surveillance in detecting the emergence of new MRSA clones in a healthcare facility